20/01/2021 10:35 am Welcome to isteroids.com - BLOG

Thursday 29, Jul 2010

  Tumor progression could be delayed with Avastin

Posted By
Pin it Share on Tumblr

Tumor progression could be delayed with AvastinA retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance has suggested that the use of Avastin to treat a subgroup of recurrent Grade 3 brain tumors is safe and effective at the same time.

Bevacizumab (also known as Avastin) emerges out as a potential therapy for gliomas, according to Marc Chamberlain, who is director of the Neuro-oncology Program at the SCCA and a professor of neurology and neurological surgery at the University of Washington School of Medicine and author of the study.

It is worthwhile to note here that Avastin is the first-approved therapy to inhibit angiogenesis, which is the process wherein new blood vessels are developed and important nutrients are transported to a tumor.

Wednesday 27, Jan 2010

  Brain tumor progression in recurrent disease can be delayed by Avastin

Posted By
Pin it Share on Tumblr

Brain tumor progression in recurrent disease can be delayed by AvastinAccording to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance, the use of Avastin alone can prove to be an effective treatment option when it comes to curing a subgroup of recurrent Grade 3 brain tumors in terms of delaying tumor progression.

Avastin, known generically as bevacizumab, is the first-ever approved therapy that has been designed for inhibiting angiogenesis that is a process by which new blood vessels develop and transport important nutrients to a tumor.

Marc Chamberlain, M.D., author of the study published in the April 15 edition of the journal Cancer and director of the Neuro-oncology Program at the SCCA and a professor of neurology and neurological surgery at the University Of Washington School Of Medicine, said that bevacizumab has the unique potential of being the best palliative treatment.

Monday 04, Jan 2010

  Avastin helpful for delaying brain tumor progression

Posted By
Pin it Share on Tumblr

Avastin helpful for delaying brain tumor progressionAs per a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance, the usage of Avastin in alone can prove helpful in treating a subgroup of recurrent Grade 3 brain tumors.

It was revealed that this drug is not only safe but also effective in delaying progression.

Avastin, known generically as bevacizumab, is the first approved therapy that is designed for inhibiting angiogenesis.

Chamberlain, director of the Neuro-oncology Program at the SCCA and a professor of neurology and neurological surgery at the University Of Washington School Of Medicine, remarked that bevacizumab has the unique potential of being the most effective form of palliative treatment.